Leishmania is transmitted to its mammalian host by the bite of phlebotomine sand flies. Within the mammalian host, Leishmania is an obligate intracellular parasite of macrophages. Immunity to leishmaniasis appears to be due to the elaboration of macrophage activating factors by parasite specific T cells which allow the macrophage to destroy its parasite burden. It is, however, surprising that this specific immunity is required since Leishmania can be readily destroyed by host non-specific immune forces (e.g., complement) and, within the macrophage, the parasite must somehow survive in the hostile environment of the phagolysosome. A partial answer to this enigma has been supplied by the work of Sacks and colleagues who described metacyclic forms of Leishmania which develop in the sand fly and are more resistant to degradation by complement and macrophages. However, the metacyclic parasites were still not completely resistant to either of these host defense mechanisms. Therefore, the parasite is likely to have other means by which it evades these initial non-specific host defense mechanisms as well as the later onslaught of specific T cell immunity. When the sand fly bites the mammalian host, it salivates into the skin. The saliva of the fly contains a number of potent pharmacological activities and it has recently been shown in the applicant's laboratory that sand fly saliva dramatically enhances Leishmania infectivity for mice and blocks macrophage activation. It therefore becomes important to examine the effect of saliva from various species of sand flies on Leishmania and on macrophage functions. These studies will be performed on both a biochemical and molecular level and could result in the description of novel forms of immunoregulation. The experiments will also attempt to characterize and isolate the various activities found in sand fly saliva in order to determine the mode of action of each substance. Finally, it is possible that in nature sand fly saliva is critical to the initiation of infection with Leishmania in the mammalian host, and, if its activity were neutralized, infection would be prevented. Therefore, animals will be immunized with saliva, or the relevant components thereof, in an attempt to vaccinate against leishmaniasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI027511-01A1
Application #
3141766
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1989-07-01
Project End
1994-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Al-Wabel, Mohammad A; Tonui, Willy K; Cui, Liwang et al. (2007) Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania. Am J Trop Med Hyg 77:1060-5
Tonui, Willy K; Titus, Richard G (2007) Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice. Am J Trop Med Hyg 76:579-84
Bishop, Jeanette V; Mejia, J Santiago; Perez de Leon, Adalberto A et al. (2006) Salivary gland extracts of Culicoides sonorensis inhibit murine lymphocyte proliferation and no production by macrophages. Am J Trop Med Hyg 75:532-6
Rogers, Kathleen A; Titus, Richard G (2004) The human cytokine response to Leishmania major early after exposure to the parasite in vitro. J Parasitol 90:557-63
Theodos, Cynthia M; Morris, Robin V; Bishop, Jeanette V et al. (2004) Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major. Infect Immun 72:4486-93
Tonui, Willy K; Mejia, J Santiago; Hochberg, Lisa et al. (2004) Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major. Infect Immun 72:5654-61
Mejia, J Santiago; Moreno, Fernando; Muskus, Carlos et al. (2004) The surface-mosaic model in host-parasite relationships. Trends Parasitol 20:508-11
Rogers, Kathleen A; Titus, Richard G (2004) Characterization of the early cellular immune response to Leishmania major using peripheral blood mononuclear cells from Leishmania-naive humans. Am J Trop Med Hyg 71:568-76
Rogers, Kathleen A; Titus, Richard G (2003) Immunomodulatory effects of Maxadilan and Phlebotomus papatasi sand fly salivary gland lysates on human primary in vitro immune responses. Parasite Immunol 25:127-34
Rogers, Kathleen A; DeKrey, Gregory K; Mbow, M Lamine et al. (2002) Type 1 and type 2 responses to Leishmania major. FEMS Microbiol Lett 209:1-7

Showing the most recent 10 out of 27 publications